Predictors for adverse events following intravesical botulinum toxin injections in men.
Luis RibeiroLap Yan LeungNataniel TanZhi-Yang LowMathura NagarajahGhazia AhmedMikaela CareySamer SabbaghDavendra SharmaJai SethPublished in: Neurourology and urodynamics (2023)
This is the first study assessing risk factors of adverse events among men following BTX-A injection. High PVR and BTX-A dose of >100U were predictors of requiring ISC after BTX-A. Stress incontinence, previous radical prostatectomy, and BOO surgery were all protective against needing ISC post-BTX-A. An enlarged prostate was associated with development of UTI. These factors can be used to assist in counseling male patients regarding their risk of ISC and UTI.
Keyphrases
- radical prostatectomy
- prostate cancer
- botulinum toxin
- risk factors
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- minimally invasive
- urinary tract infection
- ultrasound guided
- middle aged
- prognostic factors
- peritoneal dialysis
- patient reported outcomes
- coronary artery disease
- acute coronary syndrome
- benign prostatic hyperplasia
- urinary tract